Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
30
BNTX Quote, Financials, Valuation and Earnings
Last price:
$95.13
Seasonality move
:
-9.09%
Day range:
$94.69 - $96.19
52-week range:
$81.20 - $129.27
Dividend yield:
0%
P/E ratio:
191.55x
P/S ratio:
6.47x
P/B ratio:
1.05x
Volume:
3.2M
Avg. volume:
1.5M
1-year change:
-16.74%
Market cap:
$22.9B
Revenue:
$3B
EPS (TTM):
-$2.63
Earnings Data
Next earnings date for BNTX
Mar 10
2026
Most recent earnings per share
-$0.14
Missed by $0.26
(Nov 3/2025)
Consensus Estimate
$0.12
(Nov 3/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BNTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2026 | Q4 | $964.2M | -- | -- | -$0.07 | -- |
| 11/03/2025 | Q3 | $1.2B | $1.8B | -$0.14 | $0.12 | -$0.26 |
| 08/04/2025 | Q2 | $321.6M | $295.8M | -$1.82 | -$1.63 | -$0.20 |
| 05/05/2025 | Q1 | $183.4M | $192.4M | -$1.82 | -$2.66 | $0.84 |
| 03/10/2025 | Q4 | $1.2B | $1.3B | $1.15 | $0.40 | $0.75 |
| 11/04/2024 | Q3 | $561.1M | $1.4B | $0.90 | -$1.75 | $2.65 |
| 08/05/2024 | Q2 | $146.9M | $138.6M | -$3.62 | -$2.21 | -$1.41 |
| 05/06/2024 | Q1 | $399.4M | $203.8M | -$1.42 | -$1.45 | $0.02 |
| 03/20/2024 | Q4 | $2B | $1.6B | $2.04 | $2.66 | -$0.62 |
| 11/06/2023 | Q3 | -- | -- | $0.73 | -$0.71 | $1.44 |
| 08/07/2023 | Q2 | -- | -- | -$0.86 | -$0.80 | -$0.07 |
| 05/08/2023 | Q1 | -- | -- | $2.20 | $0.57 | $1.63 |
| 03/27/2023 | Q4 | -- | -- | $9.47 | $8.42 | $1.05 |
| 11/07/2022 | Q3 | -- | -- | $7.03 | $3.39 | $3.64 |
| 08/08/2022 | Q2 | -- | -- | $6.87 | $7.19 | -$0.32 |
| 05/09/2022 | Q1 | -- | -- | $15.98 | $9.62 | $6.36 |
| 03/30/2022 | Q4 | -- | -- | $13.92 | $8.30 | $5.62 |
| 11/09/2021 | Q3 | -- | -- | $15.61 | $12.19 | $3.42 |
| 08/09/2021 | Q2 | -- | -- | $12.98 | $8.96 | $4.02 |
| 05/10/2021 | Q1 | -- | -- | $5.29 | $4.36 | $0.93 |
| 03/30/2021 | Q4 | -- | -- | $1.81 | -$0.35 | $2.16 |
| 11/10/2020 | Q3 | -- | -- | -$1.03 | -$0.47 | -$0.55 |
| 08/11/2020 | Q2 | -- | -- | -$0.42 | -- | -- |
| 05/12/2020 | Q1 | -- | -- | -$0.26 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.28 | -- | -- |
| 11/14/2019 | Q3 | -- | -- | -$0.15 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -- | -- | -- |
BioNTech SE Earnings Questions
-
How Much did BioNTech SE Generate in Revenue Last Quarter?
BioNTech SE reported $1.8B worth of top line sales in its most recent quarter.
-
Did BioNTech SE Beat Earnings Last Quarter?
BioNTech SE announced earnings per share of -$0.14 which represents a miss of analyst forecast a $0.12 per share.
-
Is BioNTech SE Profitable?
BioNTech SE reported $1.6B that represents $6.66 per share over the last quarter.
-
What is the Analyst Consensus for BioNTech SE EPS Next Year?
BioNTech SE's earnings are forecast to decrease from -$2.99 per share to -$3.54 per share next year representing a decrease of -33.65%.
-
When is BioNTech SE's Earnings Date?
BioNTech SE's next earnings date is March 10, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
